Interestingly, LTP inhibition by Smad3 deficiency may be completely rescued by blocking GABAAR with picrotoxin, suggesting that treatment with a GABAAR antagonist may be a potential therapy for cognitive impairment in PD [126]. Here, SMAD3 is linked to Parkinson disease.